Heb grocery store market
Visit a quote page and your recently viewed tickers will be displayed here. Hemispherx Biopharma Enhances Ampligen Manufacturing and Scientific Capabilities. Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon.
The company was founded in August and is headquartered in Philadelphia, PA. By using this site you agree to the Terms of ServicePrivacy Policyand Cookie Policy.
Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U. Intraday data delayed at least 15 minutes or per exchange requirements.
Storyful, a division of News Corp, which owns MarketWatch, is a leading social media services company headquartered in Dublin, Ireland. Storyful combines world class journalism with industry-leading technology to discover, verify and acquire original content and provide the on-the-ground sources news and media organizations need to tell the stories that matter to their audience.
US Europe Asia FX Rates Futures Range 1D 5D 1M 3M 6M 1Y 2Y FTSE 7, Latest News All Times Eastern. Home Investing Quotes Stocks United States HEB Overview Compare Quotes Stock Screener Earnings Calendar Sectors Amex. Watch list Create HEB Alert. Jun 21, Advanced Charting 1D 5D 1M 3M 6M YTD 1Y 3Y All. Customize MarketWatch Have Watchlists? Log in to see them here or sign up to get started. Create Account … or Log In. No Items in Watchlist There are currently no items in this Watchlist.
Add Ticker to Watchlist. Go to Your Watchlist. No Saved Watchlists Create a list of the investments you want to track. Create Watchlist …or try this starter list. Uh oh Something went wrong while loading Watchlist. No Recent Tickers Visit a quote page and your recently viewed tickers will be displayed here. Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
Performance 5 Day Recent News MarketWatch Other Dow Jones Tiny biotech says it may have an answer for Ebola Feb.
ET by Russ Britt. ET by Nigam Arora. Wednesday's biggest gaining and declining stocks Dec. Dyax, Santarus, CytRx soar; Hemispherx craters Dec. ET by Val Brickates Kennedy. Stocks in focus for Wednesday Dec. Ford tips higher, Santarus surges in late session Dec.
Homepage - Central Market
ET by Laura Mandaro. I have to eat crow over these stupid picks Jun. ET by Chuck Jaffe. Vaccine makers get boost from flu scare May. Hemispherx leads drug stocks lower May. Reddy's, Hemispherx lead drug stocks May.
Pigs will get slaughtered on swine-flu stocks Apr. Shares of antiviral drugmakers rocket on flu news Apr. Niche heb grocery store market drugmakers rocket on flu news Apr. Hemispherx started at mkt outperform: ET by Tomi Kilgore. Psychology of the stock market g.
selden.pdf biggest stock gainers and decliners Aug. ET by Michael Baron. Short sellers dwindle as multiple forces aim to thwart strategy Jun. ET by Alistair Barr. Highlights of rising and falling U. Bird-flu concerns knock airlines, Asian currencies May. ET by Steve Goldstein. Drug stock market crash of 1929 beginning mixed, bird-flu drugmakers rally May.
Homepage - Central Market
Shareholder Suit Involving Loser-Pays Provision Heats Up in Delaware Jul. ET on The Wall Street Journal. Panel Rejects Drug for Chronic Fatigue Syndrome Dec.
FDA Questions Hemispherx's Fatigue Drug Dec. Potential Drug for Chronic Fatigue Syndrome to Get New Review Dec. DRDGold's Shares Rise; BioFuel Energy Soars Dec. Avian Flu News Tracker Apr. Drugs in Pipeline for Treating MS Feb. Short-Seller Trades Blows With Target Who Won't Fold Jun. Indictment Handed Up In Monroe Parker Case Jun. Readers Fare Better Than Pros in Contest Apr.
Three Internet Firms To Test IPO Waters Sep. Small-Caps Post Gains, Outpacing Blue-Chips Sep. Recent News Other News Press Releases Congo clears Merck's Ebola vaccine Congo clears Merck's Ebola vaccine May. ET on Seeking Alpha. EHTH, OPK, DKL, WGO InsiderInsights. EHTH, OPK, DKL, WGO Apr. Hemispherx's HEB CEO Thomas Equels on Q3 Results - Earnings Call Transcript Nov.
Trend reversal indicator forex OKs new cell culture-derived flu vaccine May.
Hemispherx's HEB Usd to pkr forex.pk Tom Equels on Q1 Results - Earnings Call Transcript May. Hemispherx Biopharma's HEB CEO William Carter on Q4 Results - Earnings Call Transcript Mar. Hemispherx Biopharma's HEB CEO Thomas Equels on Q4 Results - Earnings Call Transcript Mar. Can Hemispherx Get On Track After Its February Shake-Up?
Hemispherx Bio chief gets the hook Feb. Are There Any Small Biotechnology Companies With An Answer To The Zika Virus Question? Hemispherx expects production delays after flood at Alferon facility Jan.
Hemispherx Biopharma Repurposes Ampligen in Immuno-Oncology Hemispherx Biopharma Repurposes Ampligen in Immuno-Oncology May. Hemispherx Biopharma Enhances Ampligen Manufacturing and Scientific Capabilities Hemispherx Biopharma Enhances Ampligen Manufacturing and Scientific Capabilities May. Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, May.
Meets Ampligen Sales Milestone in the 1st Quarter of Mar. Hemispherx Announces First Shipment of Newly Manufactured Rintatolimod Ampligen R for Sale to Early Access Program in Europe Jan. Worthy Start of the Year for Biotech Companies Jan.
ET on PR Newswire - PRF. Hemispherx Biopharma Announces Extension of Rintatolimod European Early Access Program EAP to Pancreatic Cancer Patients Jan. Crystal Research Associates, LLC Issues Executive Informational Overview on Hemispherx Biopharma, Inc. Hemispherx Biopharma to Present at the 9th Annual LD Micro Main Event Nov. Hemispherx Biopharma Announces Financial Results in its Quarterly Report for the Nine Months Ended September 30, Nov.
Hemispherx Biopharma Announces Conference Call to Provide Quarterly Business Update on November 15, Nov.
Hemispherx Biopharma Featured in Corporate America News Magazine Special Report "Capturing the Power of Immune Response to Treat Disease: Biotech Bounce Back" Nov. Hemispherx Biopharma Announces Completion of Ampligen R Manufacturing Technology Transfer Milestone Oct. Hemispherx Biopharma Announces Granting of Final Settlement of Derivative and Class Action Case Sep. Hemispherx Biopharma Regains Compliance with NYSE MKT Continued Listing Standards Sep. Hemispherx Biopharma Forms Scientific Advisory Board to Provide Additional Scientific and Pharmaceutical Expertise Aug.
Ebola Sector Shake Out Leaves Chimerix Inc On Top Oct. MarketWatch Site Index Topics Help Feedback Newsroom Roster Media Archive Premium Products Mobile. Dow Jones Network WSJ. Trending Tickers Powered by USO Valeant Pharmaceuticals International Inc.